Dynamic	O
switching	O
of	O
active	O
promoter	O
and	O
enhancer	O
domains	O
regulates	O
Tet1	O
and	O
Tet2	O
expression	O
during	O
cell	O
state	O
transitions	O
between	O
pluripotency	O
and	O
differentiation	O
.	O


The	O
Tet	O
5	O
-	O
methylcytosine	O
dioxygenases	O
catalyze	O
DNA	O
demethylation	O
by	O
producing	O
5	O
-	O
hydroxymethylcytosine	O
and	O
further	O
oxidized	O
products	O
.	O


Tet1	O
and	O
Tet2	O
are	O
highly	O
expressed	O
in	O
mouse	O
pluripotent	O
cells	O
and	O
downregulated	O
to	O
different	O
extents	O
in	O
somatic	B-TISSUE
cells	E-TISSUE
,	O
but	O
the	O
transcriptional	O
mechanisms	O
are	O
unclear	O
.	O


Here	O
we	O
defined	O
the	O
promoter	O
and	O
enhancer	O
domains	O
in	O
Tet1	O
and	O
Tet2	O
.	O


Within	O
a	O
15	O
-	O
kb	O
"	O
superenhancer	O
"	O
of	O
Tet1	O
,	O
there	O
are	O
two	O
transcription	O
start	O
sites	O
(	O
TSSs	O
)	O
with	O
different	O
activation	O
patterns	O
during	O
development	O
.	O


A	O
6	O
-	O
kb	O
promoter	O
region	O
upstream	O
of	O
the	O
distal	O
TSS	O
is	O
highly	O
active	O
in	O
naive	O
pluripotent	O
cells	O
,	O
autonomously	O
reports	O
Tet1	O
expression	O
in	O
a	O
transgenic	O
system	O
,	O
and	O
rapidly	O
undergoes	O
DNA	O
methylation	O
and	O
silencing	O
upon	O
differentiation	O
in	O
cultured	O
cells	O
and	O
native	O
epiblast	S-TISSUE
.	O


A	O
second	O
TSS	O
downstream	O
,	O
associated	O
with	O
a	O
constitutively	O
weak	O
CpG	O
-	O
rich	O
promoter	O
,	O
is	O
activated	O
by	O
a	O
neighboring	O
enhancer	O
in	O
naive	O
embryonic	B-TISSUE
stem	I-TISSUE
cells	E-TISSUE
(	O
ESCs	S-TISSUE
)	O
and	O
primed	O
epiblast	B-TISSUE
-	I-TISSUE
like	I-TISSUE
cells	E-TISSUE
(	O
EpiLCs	S-TISSUE
)	O
.	O


Tet2	O
has	O
a	O
CpG	O
island	O
promoter	O
with	O
pluripotency	O
-	O
independent	O
activity	O
and	O
an	O
ESC	S-TISSUE
-	O
specific	O
distal	O
intragenic	O
enhancer	O
;	O
the	O
latter	O
is	O
rapidly	O
downregulated	O
in	O
EpiLCs	S-TISSUE
.	O


Our	O
study	O
reveals	O
distinct	O
modes	O
of	O
transcriptional	O
regulation	O
at	O
Tet1	O
and	O
Tet2	O
during	O
cell	O
state	O
transitions	O
of	O
early	O
development	O
.	O


New	O
transgenic	O
reporters	O
using	O
Tet1	O
and	O
Tet2	O
cis	O
-	O
regulatory	O
domains	O
may	O
serve	O
to	O
distinguish	O
nuanced	O
changes	O
in	O
pluripotent	O
states	O
and	O
the	O
underlying	O
epigenetic	O
variations	O
.	O
